Advances in Care host Erin Welsh sits down with sports medicine physician and concussion specialist Dr. Thomas Bottiglieri to explore the current landscape of concussion care, limitations in assessment, and how a newly discovered biomarker may be the key to more accurate diagnosis and return-to-play decisions. After Dr. Bottiglieri and his team identified a unique biomarker linked to severe concussion, they developed ProScope: an eyetracking software tool that measures head and neck stability and detects the diagnostic biomarker with more than 80% sensitivity. Now, for the first time, clinicians can objectively diagnose and measure the severity of concussion. ProScope even has the potential to be used directly on the sidelines, giving clinicians a faster, and more accurate way to assess athletes for concussion immediately after injury.